Celgene Ducks Teva Unit's Breast-Cancer Drug IP Claims

Celgene Ducks Teva Unit's Breast-Cancer Drug IP Claims

A Massachusetts federal judge entered an order Tuesday clearing Celgene Corp. of allegations that its anti-tumor drug Abraxane infringed a Teva Pharmaceutical Industries Ltd. unit's patent covering the drug's active ingredient, after the parties ...read more

  • Tags: